Neoadjuvant CTx | Surgery n | |
---|---|---|
(n = 26/64) | (n = 38/64) | |
Age | ||
Median (years) | 64.5 | 73 |
(range) | (38–76) | (43–91) |
Sex | ||
Males | 20 | 23 |
Females | 6 | 15 |
Tumor localization | ||
Proximal | 20 | 26 |
Distal | 6 | 12 |
Surgical procedure | ||
Total gastrectomy | 25 | 31 |
Subtotal gastrectomy | 1 | 7 |
D2-lymphadenectomy | 26 | 38 |
Resection | ||
Curative (R0) | 20 | 28 |
Palliative (R1) | 6 | 10 |
UICC stage, pretherapeutic | ||
Ib | 2 | 10 |
II | 7 | 13 |
III | 17 | 15 |
WHO classification | ||
Adenocarcinoma | 20 | 31 |
Signet-cell carcinoma | 6 | 7 |
Grading | ||
G 1-2 | 6 | 21 |
G 3 | 20 | 17 |
Lauren-classification | ||
Intestinal | 15 | 21 |
Diffuse | 11 | 17 |